PURCHASE AND SALE AGREEMENT DATED AS OF FEBRUARY 2, 2017 BETWEEN PORTOLA PHARMACEUTICALS, INC., AS SELLER, AND THE ENTITIES MANAGED BY HEALTHCARE ROYALTY MANAGEMENT, LLC IDENTIFIED HEREIN, COLLECTIVELY AS PURCHASERPurchase and Sale Agreement • June 14th, 2021 • Healthcare Royalty, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 14th, 2021 Company Industry JurisdictionThis PURCHASE AND SALE AGREEMENT (this “Agreement”) dated as of February 2, 2017 is between PORTOLA PHARMACEUTICALS, INC., a Delaware corporation (the “Seller”), and the entities managed by HealthCare Royalty Management, LLC set forth on Annex I (collectively, the “Purchaser”). Each of Seller and Purchaser are referred to in this Agreement as a “Party” and collectively as the “Parties”.
PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • May 9th, 2017 • Portola Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2017 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.